(HealthDay)—Multimodal screening (MMS) for ovarian cancer is potentially cost-effective in the United States, according to a study published online Dec. 7 in JAMA Oncology.
Dec 8, 2017
0
8
Scientists at St. Jude Children's Research Hospital are studying how hearing loss can affect the neurocognitive abilities of childhood cancer survivors. Findings show that survivors with severe hearing loss are at a significant ...
Jul 30, 2020
0
0
A large, retrospective, multicenter study involving Washington University School of Medicine in St. Louis indicates that convalescent plasma from recovered COVID-19 patients can dramatically improve likelihood of survival ...
Jun 17, 2021
0
15
A clinical trial led by researchers at City of Hope, a world-renowned cancer research and treatment organization, showed that patients over 65 receiving chemotherapy experienced significantly fewer treatment-related side ...
Sep 30, 2021
0
29
(HealthDay)—Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors, with a decreased risk for daunorubicin versus doxorubicin, according to a study recently published in JAMA Oncology.
Mar 1, 2019
0
2
A group of international scientists say they have encountered many hurdles in accessing information for a study to examine clinical trial data used to support FDA-approved anticancer medicines even when the data was classified ...
Nov 15, 2023
0
22
When COVID-19 struck, health care pivoted hard. Any unnecessary procedures or appointments were postponed. For people with cancer, that pivot was particularly shattering.
Aug 6, 2020
0
12
Indiana University School of Medicine researchers Milan Radovich, Ph.D., and Bryan Schneider, MD, have discovered that the presence of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) in the plasma of women's ...
Jul 9, 2020
0
3
New research published today in JAMA Oncology reports how two separate DNA changes appear to predict aggressive childhood leukemias when they occur in combination. Over the course of a decade of work in several study sites ...
Aug 20, 2021
0
129
Redispensing cancer drugs reduces both environmental impact and medical costs, according to research from Radboudumc pharmacy published in JAMA Oncology. The annual savings could amount to tens of millions.
Nov 17, 2023
0
0
